Invention Grant
- Patent Title: Treating cardiovascular disease with TRPC3 channel protein
- Patent Title (中): 用TRPC3通道蛋白治疗心血管疾病
-
Application No.: US12897892Application Date: 2010-10-05
-
Publication No.: US08030276B2Publication Date: 2011-10-04
- Inventor: Carsten Struebing
- Applicant: Carsten Struebing
- Applicant Address: FR Paris
- Assignee: Sanofi-Aventis
- Current Assignee: Sanofi-Aventis
- Current Assignee Address: FR Paris
- Priority: EP05000440 20050112
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/00
Abstract:
The invention refers to the use of a TRPC channel, an inactivating mutant thereof, or a nucleotide sequence coding for the TRPC channel or for the inactivating mutant for the production of a medicament for the treatment of a cardiovascular disease and a method of screening a modulator of the TRPC channel or an inactivating mutant thereof.
Public/Granted literature
- US20110021377A1 USE OF A TRPC CHANNEL FOR THE TREATMENT OF A CARDIOVASCULAR DISEASE Public/Granted day:2011-01-27
Information query
IPC分类:
